BIOLASE, Inc. (BIOL)
NASDAQ: BIOL · IEX Real-Time Price · USD
0.148
-0.003 (-2.11%)
At close: Apr 30, 2024, 4:00 PM
0.147
-0.001 (-0.88%)
After-hours: Apr 30, 2024, 7:59 PM EDT
BIOLASE Revenue
In the year 2023, BIOLASE had annual revenue of $49.16M with 1.45% growth. Revenue in the quarter ending December 31, 2023 was $13.49M, a -3.99% decrease year-over-year.
Revenue (ttm)
$49.16M
Revenue Growth
+1.45%
P/S Ratio
0.10
Revenue / Employee
$313,146
Employees
157
Market Cap
4.93M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 49.16M | 702.00K | 1.45% |
Dec 31, 2022 | 48.46M | 9.27M | 23.67% |
Dec 31, 2021 | 39.19M | 16.41M | 72.03% |
Dec 31, 2020 | 22.78M | -15.02M | -39.73% |
Dec 31, 2019 | 37.80M | -8.36M | -18.10% |
Dec 31, 2018 | 46.16M | -771.00K | -1.64% |
Dec 31, 2017 | 46.93M | -4.88M | -9.43% |
Dec 31, 2016 | 51.81M | 3.34M | 6.88% |
Dec 31, 2015 | 48.48M | 819.00K | 1.72% |
Dec 31, 2014 | 47.66M | -8.77M | -15.55% |
Dec 31, 2013 | 56.43M | -926.00K | -1.61% |
Dec 31, 2012 | 57.36M | 8.50M | 17.39% |
Dec 31, 2011 | 48.86M | 22.63M | 86.30% |
Dec 31, 2010 | 26.23M | -17.12M | -39.50% |
Dec 31, 2009 | 43.35M | -21.28M | -32.93% |
Dec 31, 2008 | 64.63M | -2.26M | -3.38% |
Dec 31, 2007 | 66.89M | -2.81M | -4.03% |
Dec 31, 2006 | 69.70M | 7.72M | 12.46% |
Dec 31, 2005 | 61.98M | 1.33M | 2.19% |
Dec 31, 2004 | 60.65M | 11.87M | 24.33% |
Dec 31, 2003 | 48.78M | 21.53M | 78.97% |
Dec 31, 2002 | 27.26M | 10.71M | 64.73% |
Dec 31, 2001 | 16.55M | 7.05M | 74.26% |
Dec 31, 2000 | 9.50M | 2.49M | 35.57% |
Dec 31, 1999 | 7.00M | 5.54M | 378.03% |
Dec 31, 1998 | 1.47M | -321.09K | -17.98% |
Dec 31, 1997 | 1.79M | 1.09M | 158.20% |
Dec 31, 1996 | 691.83K | -460.35K | -39.95% |
Dec 31, 1995 | 1.15M | 16.45K | 1.45% |
Dec 31, 1994 | 1.14M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
China Jo-Jo Drugstores | 154.66M |
Leafly Holdings | 42.25M |
ThermoGenesis Holdings | 9.45M |
Acutus Medical | 7.16M |
Sintx Technologies | 2.63M |
Silo Pharma | 72.10K |
BIOL News
- 5 weeks ago - Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 - Accesswire
- 6 weeks ago - BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 - Accesswire
- 2 months ago - Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry - Accesswire
- 2 months ago - Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental' - Accesswire
- 2 months ago - BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering - Accesswire
- 2 months ago - BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement - Accesswire
- 2 months ago - BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering - Accesswire
- 2 months ago - Top 5 Health Care Stocks That Are Preparing To Pump In February - Benzinga